Clinical Trial Update: Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial evaluating cholesterol-disruption in combination with standard of care for advanced pancreatic ductal adenocarcinoma; the study is active b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: CHU de Quebec-Universite Laval | Conditions: Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING